arrow
R

Renato Santana Aguiar

Universidade Federal do Rio de Janeiro
H指数:40
被引数:9,498

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Distinct ZIKV strain signatures and type I IFN modulation reveal a protective role of brain endothelial interferon signaling in vitro and in vivo

更正:独特的ZIKV毒株特征和I型干扰素调控揭示了脑内皮细胞干扰素信号在体外和体内的保护作用

2025-12-170
OAAI
The Neuroimmunome of Hepatitis Patients Associates With Disease Severity

肝炎患者的神经免疫组学与疾病严重程度相关

2025-12-050
OAAI
Distinct ZIKV strain signatures and type I IFN modulation reveal a protective role of brain endothelial interferon signaling in vitro and in vivo

不同ZIKV菌株特征和I型IFN调节揭示了脑内皮细胞干扰素信号在体外和体内的保护作用

2025-12-030
OAAI
Expanding the molecular characterization of adenoid ameloblastoma by assessing a panel of oncogenes and tumor suppressor genes

通过评估一组癌基因和肿瘤抑制基因,扩展腺样成釉细胞瘤的分子特征分析

2025-10-160
PRE
Neuropsychiatric sequelae in an experimental model of post-COVID syndrome in mice

小鼠后COVID综合征实验模型中的神经精神后遗症

2025-06-040
OAAI
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)

氟西汀在早期有症状COVID-19中的抗病毒疗效:一项开放标签、随机对照、适应性平台试验(PLATCOV)

2025-02-010
OAAI
Functional heterogeneity of mesenchymal stem cells and their therapeutic potential in the K18-hACE2 mouse model of SARS-CoV-2 infection
2025-01-230
OAAI
Retrospective epidemiologic and genomic surveillance of arboviruses in 2023 in Brazil reveals high co-circulation of chikungunya and dengue viruses
2024-11-201
OAAI
SARS-CoV-2 surveillance in captive animals at the belo horizonte zoo, Minas Gerais, Brazil
2024-11-191
OAAI
Oropouche virus genomic surveillance in Brazil
2024-11-011
PRE
E3 Ubiquitin Ligase Smurf1 Regulates the Inflammatory Response in Macrophages and Attenuates Hepatic Damage during Betacoronavirus Infection

E3泛素连接酶Smurf1调节巨噬细胞的炎症反应并减轻 β 冠状病毒感染期间的肝损伤

2024-10-030
OAAI
Retrospective Analysis of Omicron in Minas Gerais, Brazil: Emergence, Dissemination, and Diversification
2024-08-230
OAAI
Changes in neuroinflammatory biomarkers correlate with disease severity and neuroimaging alterations in patients with COVID-19 neurological complications
2024-08-014
OAAI
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
2024-01-1811
OAAI
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

favipiravir在早期新型冠状病毒肺炎中的临床抗病毒疗效 (PLATCOV): 一项开放标签,随机,对照,自适应平台试验

2024-01-1512
OAAI
Lessons from a Multilaboratorial Task Force for Diagnosis of a Fatal Toxoplasmosis Outbreak in Captive Primates in Brazil
2023-11-292
OAAI
Epidemiological and genomic investigation of chikungunya virus in Rio de Janeiro state, Brazil, between 2015 and 2018
2023-09-285
OAAI
Molecular detection and characterization of SARS-CoV-2 in cats and dogs of positive owners during the first COVID-19 wave in Brazil
2023-09-024
OAAI
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)

Remdesivir在冠状病毒疾病中的临床抗病毒疗效2019: 一项开放标签,随机对照自适应平台试验 (PLATCOV)

2023-07-2012
OAAI